TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35917806

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin 40 IU
Number of subjects: 42

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 42
Study: 33298193

Group type: EXPERIMENTAL
Intervention: Interpersonal Counselling for Adolescents (IPC-A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 60
Study: 35816836

Group type: EXPERIMENTAL
Intervention: Household food insecurity (FI)
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Higher baseline BMI
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Dietary quality (measured by USDA Healthy Eating Index)
Number of subjects: 534
Study: 33957531

Group type: EXPERIMENTAL
Intervention: Medial Displacement Calcaneal Osteotomy (MDCO)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Lateral Column Lengthening (LCL)
Number of subjects: 42
Study: 35620325

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MedDiet)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Healthy Eating Guidelines (HEG)
Number of subjects: 44
Study: 34861827

Group type: EXPERIMENTAL
Intervention: CRAFT delivered through individual sessions
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CRAFT delivered through group sessions
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CRAFT written material as a supplement
Number of subjects: 11
Study: 34487222

Group type: EXPERIMENTAL
Intervention: Calorie-restricted ketogenic diet and intermittent fasting (KD-IF)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard diet (SD)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low glucose
Number of subjects: 50
Study: 33831623

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control (no inhaled salbutamol)
Number of subjects: 57
Study: 33739358

Group type: EXPERIMENTAL
Intervention: Sending 21 email messages to family pediatricians
Number of subjects: 141
Study: 34975166

Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Butorphanol (BUT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 40
Study: 33824226

Group type: EXPERIMENTAL
Intervention: Choir intervention (2-hr ensemble singing + 1-hr home vocal training weekly)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choir intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (listened to a 3-hr playlist weekly, attended concerts, and socialized online)
Number of subjects: 0
Study: 35275776

Group type: EXPERIMENTAL
Intervention: Automated cycloplegic refraction using Retinomax K‐plus 5
Number of subjects: 213

Group type: COMPARATOR
Intervention: Manual cycloplegic refraction using retinoscopy
Number of subjects: 213
Study: 32302064

Group type: EXPERIMENTAL
Intervention: Calcium glucoheptonate (250 mg/10 mL, two oral ampoules)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Calcium carbonate (500 mg elemental calcium, one effervescent tablet)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Calcium glucoheptonate and Calcium carbonate
Number of subjects: 24
Study: 35984522

Group type: EXPERIMENTAL
Intervention: Low‐cost simulated pelvic model for kinesthetic learning during the video module
Number of subjects: 40

Group type: COMPARATOR
Intervention: Interactive video module alone
Number of subjects: 40
Study: 34326053

Group type: EXPERIMENTAL
Intervention: Identification of open bile ducts with administration of 20-40 mL SMOFlipid5% in the bile tract
Number of subjects: 210

Group type: COMPARATOR
Intervention: Identification with a white gauze on the liver resection surface
Number of subjects: 210
Study: 33213722

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 2365

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 2365
Study: 35348447

Group type: EXPERIMENTAL
Intervention: Nomogram model for overall survival (OS)
Number of subjects: 3061

Group type: EXPERIMENTAL
Intervention: Nomogram model for cancer-specific survival (CSS)
Number of subjects: 3061

Group type: EXPERIMENTAL
Intervention: Nomogram model
Number of subjects: 3061
Study: 32852889

Group type: EXPERIMENTAL
Intervention: Manuka honey irrigation
Number of subjects: 13
Study: 35190884

Group type: EXPERIMENTAL
Intervention: Cention N®
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: EQUIA Forte®
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Filtek™ Z350
Number of subjects: 66
Study: 34518246

Group type: EXPERIMENTAL
Intervention: Friendship Bench (FB) intervention, details on dosage and duration not specified.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cluster randomised controlled trial of the optimised Friendship Bench intervention, details on dosage and duration not specified.
Number of subjects: 0
Study: 35062944

Group type: EXPERIMENTAL
Intervention: Non-invasive pursed lip breathing ventilation (PLBV) during the second night of the study
Number of subjects: 31

Group type: COMPARATOR
Intervention: Established non-invasive ventilation (NIV) treatment
Number of subjects: 31
Study: 34078374

Group type: EXPERIMENTAL
Intervention: STAR (Sepsis Transition and Recovery program)
Number of subjects: 4032

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 4032
Study: 32502072

Group type: EXPERIMENTAL
Intervention: Thermal Grill Illusion (TGI) with neutral, positive (placebo), and negative (nocebo) instructions
Number of subjects: 64

Group type: COMPARATOR
Intervention: Single-temperature stimulation
Number of subjects: 64
Study: 34570177

Group type: EXPERIMENTAL
Intervention: Levetiracetam, 125 mg, twice daily for 4 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo, twice daily for 4 weeks
Number of subjects: 34
Study: 32205751

Group type: EXPERIMENTAL
Intervention: Intradermal injection of botulinum toxin (8U)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Intramuscular injection of botulinum toxin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study: 36224574

Group type: EXPERIMENTAL
Intervention: Online technology (OLT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Paper format (PF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both OLT and PF
Number of subjects: 40
Study: 33323473

Group type: EXPERIMENTAL
Intervention: Steering immunosuppressive therapy by levels of virus-specific T cells
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group with trough-level monitoring of immunosuppressants
Number of subjects: 64
Study: 33177722

Group type: EXPERIMENTAL
Intervention: Postpartum rehabilitation nursing (n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (n=50)
Number of subjects: 100
Study: 33955170

Group type: EXPERIMENTAL
Intervention: HIVRR + MF intervention
Number of subjects: 354

Group type: COMPARATOR
Intervention: HIVRR intervention
Number of subjects: 354
Study: 32202350

Group type: EXPERIMENTAL
Intervention: Medicinal plant mix (wormwood, chamomile, fumitory, and mallow) with meadow hay:barley grain (MH:B) in a ratio of 100/600/300 w/w/w
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single plant substrates (wormwood, chamomile, fumitory, and mallow)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (MH:B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total polyphenols content in plant extracts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ciliate protozoan population in rumen fluid after 24 hr of fermentation
Number of subjects: 0
Study: 35102098

Group type: EXPERIMENTAL
Intervention: FSFI‐19 <21
Number of subjects: 998
Study: 34515737

Group type: EXPERIMENTAL
Intervention: CONNECT intervention (3 monthly visits with trained oncology nurses)
Number of subjects: 672
Study: 33393675

Group type: EXPERIMENTAL
Intervention: Genetically proxied inhibition of IL‐6 signalling
Number of subjects: 0
Study: 32192407

Group type: EXPERIMENTAL
Intervention: F-care
Number of subjects: 114

Group type: COMPARATOR
Intervention: Closurefast
Number of subjects: 114
Study: 32633650

Group type: EXPERIMENTAL
Intervention: Viewing nature photos
Number of subjects: 757

Group type: COMPARATOR
Intervention: Viewing urban scenes or neutral objects (control conditions)
Number of subjects: 757
Study: 32854734

Group type: EXPERIMENTAL
Intervention: Digital parental materials (online animated films and a parent-teen homework exercise)
Number of subjects: 8000
Study: 33725166

Group type: EXPERIMENTAL
Intervention: Non-surgical debridement (NST)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Surgical debridement (ST)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Comparison between NST and ST
Number of subjects: 45
Study: 33143674

Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 86188

Group type: COMPARATOR
Intervention: Statin non-users
Number of subjects: 86188
Study: 36122756

Group type: EXPERIMENTAL
Intervention: Nanocurcumin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33430913

Group type: EXPERIMENTAL
Intervention: Hemipelvis restricted group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hemipelvis unrestricted group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups when ASL, SBL, and SPL failed
Number of subjects: 14
Study: 33469657

Group type: EXPERIMENTAL
Intervention: Encephaloduroarteriosynangiosis (EDAS)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Intensive medical management (IMM)
Number of subjects: 52
Study: 32994236

Group type: EXPERIMENTAL
Intervention: Supportive bandage for 3 days
Number of subjects: 180

Group type: COMPARATOR
Intervention: Below-elbow cast for 2 weeks
Number of subjects: 180
Study: 32029039

Group type: EXPERIMENTAL
Intervention: REE group (n = 29)
Number of subjects: 58

Group type: COMPARATOR
Intervention: HBREE group (n = 29)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: REE group
Number of subjects: 58

Group type: COMPARATOR
Intervention: HBREE group
Number of subjects: 58
Study: 32090720

Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT) exercises over 15 weeks
Number of subjects: 93

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT)
Number of subjects: 93
Study: 33218561

Group type: EXPERIMENTAL
Intervention: 40% intensity PNF stretching (P40)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 10% intensity PNF stretching (P10)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 40% intensity PNF stretching with toe touch (P40 with TT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 10% intensity PNF stretching with toe touch (P10 with TT)
Number of subjects: 64
Study: 34111771

Group type: EXPERIMENTAL
Intervention: PNC-txt (peer network counseling text)
Number of subjects: 101
Study: 34326209

Group type: EXPERIMENTAL
Intervention: Nicotinamide mononucleotide (NMN) therapy
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 2
Study: 32289854

Group type: EXPERIMENTAL
Intervention: Endoscopic procedures (clipping and coagulation of visible vessels)
Number of subjects: 110
Study: 36050353

Group type: EXPERIMENTAL
Intervention: Classroom standing desk intervention for 16 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Traditional sitting classes (control)
Number of subjects: 49
Study: 33481866

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 250

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 250
Study: 32072749

Group type: EXPERIMENTAL
Intervention: 12-week lifestyle intervention including nutrition education (1 h/wk) and moderate-to-vigorous physical activity (3 h/wk)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 136
Study: 35359480

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES) 130/0.4
Number of subjects: 126

Group type: COMPARATOR
Intervention: 0.9% normal saline (NS)
Number of subjects: 126

Group type: COMPARATOR
Intervention: 6% hydroxyethyl starch (HES) 130/0.4 vs 0.9% normal saline (NS)
Number of subjects: 126
Study: 34774745

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32056358

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 48
Study: 33331805

Group type: EXPERIMENTAL
Intervention: Intervention 1: 10 min of aerobic exercise after five cycles of one minute of static stretching
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intervention 2: 10 min of aerobic exercise before static stretching
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intervention 3: 5 min of aerobic exercise both before and after static stretching
Number of subjects: 15
Study: 34098955

Group type: EXPERIMENTAL
Intervention: mepolizumab 750, 250, or 75 mg intravenously
Number of subjects: 1878

Group type: EXPERIMENTAL
Intervention: mepolizumab 75 mg intravenously or 100 mg subcutaneously
Number of subjects: 1878

Group type: EXPERIMENTAL
Intervention: mepolizumab 100 mg subcutaneously
Number of subjects: 1878

Group type: EXPERIMENTAL
Intervention: mepolizumab
Number of subjects: 1878

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1878
Study: 36001254

Group type: EXPERIMENTAL
Intervention: Peer support and mobile application-based walking programme
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 34614511

Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33054367

Group type: EXPERIMENTAL
Intervention: ACURATE neo
Number of subjects: 796

Group type: COMPARATOR
Intervention: CoreValve Evolut
Number of subjects: 796
Study: 35190385

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg/day
Number of subjects: 15
Study: 34342153

Group type: EXPERIMENTAL
Intervention: Prognostic model of the nomogram in the development group
Number of subjects: 3820

Group type: EXPERIMENTAL
Intervention: Prognostic model of the nomogram in the validation group
Number of subjects: 3820

Group type: EXPERIMENTAL
Intervention: High risk prognosis index
Number of subjects: 3820
Study: 32602376

Group type: COMPARATOR
Intervention: No sleep problems
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Sleep problems with no-to-minimal-impact
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Sleep problems with moderate-to-quite-a-bit of impact
Number of subjects: 408
Study: 35197469

Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 11500000

Group type: EXPERIMENTAL
Intervention: Older adults and individuals with comorbidities
Number of subjects: 11500000

Group type: EXPERIMENTAL
Intervention: Pragmatic RCT using non-specific endpoints
Number of subjects: 11500000
Study: 33314364

Group type: EXPERIMENTAL
Intervention: Multivariate multilevel (MM) models
Number of subjects: 0

Group type: COMPARATOR
Intervention: Univariate methods with multiple imputation
Number of subjects: 0
Study: 35535503

Group type: EXPERIMENTAL
Intervention: mRNA-1273 vaccine (100 µg)
Number of subjects: 1457

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1457
Study: 33567961

Group type: EXPERIMENTAL
Intervention: Cognitive tasks (difficult vs easy)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Catastrophizing
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fear-avoidance model variables
Number of subjects: 80
Study: 35142904

Group type: EXPERIMENTAL
Intervention: Permanent mesh
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Absorbable mesh
Number of subjects: 255

Group type: COMPARATOR
Intervention: No mesh
Number of subjects: 255
Study: 34784916

Group type: EXPERIMENTAL
Intervention: Dove Confident Me Indonesia: Single Session intervention delivered by trained teachers or school guidance counsellors
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Dove Confident Me Indonesia: Single Session intervention
Number of subjects: 2000
Study: 35074566

Group type: EXPERIMENTAL
Intervention: Normal blood glucose (euglycemia)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: High blood glucose (hyperglycemia)
Number of subjects: 26
Study: 34536595

Group type: EXPERIMENTAL
Intervention: Workshop on synthetic bone (group 1)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Theoretical instruction only (group 2)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Residents with previous experience in spinal surgery
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Residents trained by simulation
Number of subjects: 23
Study: 34387740

Group type: EXPERIMENTAL
Intervention: N-acetyl-L-leucine (NALL) 4 g/day for patients ≥ 13 years, weight-tiered doses for patients 6-12 years
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: N-acetyl-L-leucine (NALL)
Number of subjects: 33
Study: 34820034

Group type: EXPERIMENTAL
Intervention: Ergoferon
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study: 35517892

Group type: EXPERIMENTAL
Intervention: Melatonin (21 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32297703

Group type: EXPERIMENTAL
Intervention: Intrarenal artery infusion of autologous peripheral-blood-derived CD34+ cells (2.5 × 10^7 cells for each intrarenal artery)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standardized pharmacotherapy only (control group)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intrarenal artery infusion of autologous peripheral-blood-derived CD34+ cells
Number of subjects: 52
Study: 36457297

Group type: EXPERIMENTAL
Intervention: Attempted Suicide Short Intervention Program (ASSIP)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Crisis Counseling (CC)
Number of subjects: 239
Study: 33793585

Group type: EXPERIMENTAL
Intervention: Artificial teardrops for left eye and normal saline for right eye (Group A)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Polyethylene covers for left eye and normal saline for right eye (Group B)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Polyethylene covers for left eye and artificial teardrops for right eye (Group C)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Polyethylene eye covers (all groups)
Number of subjects: 79
Study: 35504735

Group type: EXPERIMENTAL
Intervention: Standardized digital photographs (ELAB)
Number of subjects: 162

Group type: COMPARATOR
Intervention: VITA Easyshade spectrophotometer (ES) (control group)
Number of subjects: 162
Study: 34559113

Group type: EXPERIMENTAL
Intervention: Chuna Manual Therapy (CMT) administered once a week for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard drug treatment (Control)
Number of subjects: 40
Study: 35449560

Group type: EXPERIMENTAL
Intervention: CIMT plus active rTMS
Number of subjects: 40

Group type: COMPARATOR
Intervention: CIMT plus sham rTMS
Number of subjects: 40
Study: 32017768

Group type: EXPERIMENTAL
Intervention: Barley genotypes infected with Fusarium culmorum spores before heading
Number of subjects: 100
Study: 34963654

Group type: EXPERIMENTAL
Intervention: Media exposure
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Stressful life events (SLE)
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Harsh parenting
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Child age and white non-Hispanic race
Number of subjects: 613

Group type: COMPARATOR
Intervention: Latent growth modeling (LGM) without covariates
Number of subjects: 613

Group type: COMPARATOR
Intervention: Latent growth modeling (LGM) with covariates
Number of subjects: 613
Study: 35149988

Group type: EXPERIMENTAL
Intervention: Strong Families, Strong Communities (SFSC) program
Number of subjects: 1249

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 1249
Study: 34968730

Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg QD
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg QD
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Dose-escalated group (upadacitinib 30 mg QD)
Number of subjects: 107
Study: 33865330

Group type: EXPERIMENTAL
Intervention: 20 ppm iNO
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0 ppm iNO
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: iCPR
Number of subjects: 10
Study: 32688046

Group type: EXPERIMENTAL
Intervention: STARC (Skills‐Training of Affect Regulation–A Culture‐sensitive Approach)
Number of subjects: 44
Study: 34192724

Group type: EXPERIMENTAL
Intervention: Case management intervention
Number of subjects: 220

Group type: COMPARATOR
Intervention: Routine HIV-related care (Control)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Both groups (Case management and Control)
Number of subjects: 220
Study: 32028914

Group type: EXPERIMENTAL
Intervention: General population
Number of subjects: 3463

Group type: EXPERIMENTAL
Intervention: Families of TB patients
Number of subjects: 3463

Group type: EXPERIMENTAL
Intervention: TB patients
Number of subjects: 3463

Group type: EXPERIMENTAL
Intervention: General population with education above secondary school
Number of subjects: 3463

Group type: EXPERIMENTAL
Intervention: General population with high knowledge about TB
Number of subjects: 3463

Group type: EXPERIMENTAL
Intervention: Families of TB patients with education above secondary school
Number of subjects: 3463

Group type: EXPERIMENTAL
Intervention: TB patients with education above secondary school
Number of subjects: 3463

Group type: EXPERIMENTAL
Intervention: TB patients in the first wealth quintile
Number of subjects: 3463

Group type: EXPERIMENTAL
Intervention: TB patients in the third wealth quintile
Number of subjects: 3463

Group type: EXPERIMENTAL
Intervention: Fear of job loss
Number of subjects: 3463

Group type: EXPERIMENTAL
Intervention: Isolation
Number of subjects: 3463

Group type: EXPERIMENTAL
Intervention: Feeling avoided
Number of subjects: 3463
Study: 37154505

Group type: EXPERIMENTAL
Intervention: Rigid catheter
Number of subjects: 50

Group type: COMPARATOR
Intervention: Soft catheter
Number of subjects: 50
Study: 34185829

Group type: EXPERIMENTAL
Intervention: DTE
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: LT4 + LT3
Number of subjects: 75

Group type: COMPARATOR
Intervention: LT4
Number of subjects: 75
Study: 32032408

Group type: EXPERIMENTAL
Intervention: FGG+HA
Number of subjects: 40

Group type: COMPARATOR
Intervention: FGG alone
Number of subjects: 40
Study: 35738801

Group type: EXPERIMENTAL
Intervention: Immune checkpoint inhibitors (ICIs) treatment for uHCC
Number of subjects: 20

Group type: COMPARATOR
Intervention: Preferable microbial signature in validation cohort
Number of subjects: 20